TrialThoracic cancer2020

A randomized clinical study to compare intrapleural infusion with intravenous infusion of bevacizumab in the management of malignant pleural effusion in patients with non-small-cell lung cancer.

Keke Nie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.